Copyright Reports & Markets. All rights reserved.

Global Bovine Blood Plasma Derivatives Market Growth 2019-2024

Request for Sample of this report
Buy now

Table of Contents

    2019-2024 Global Bovine Blood Plasma Derivatives Consumption Market Report

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Bovine Blood Plasma Derivatives Consumption 2014-2024
        • 2.1.2 Bovine Blood Plasma Derivatives Consumption CAGR by Region
      • 2.2 Bovine Blood Plasma Derivatives Segment by Type
        • 2.2.1 Bovine Serum
        • 2.2.2 FBS
        • 2.2.3 Bovine Serum Albumin
        • 2.2.4 Fibrinogen
        • 2.2.5 Protein Ingredient
        • 2.2.6 Other
      • 2.3 Bovine Blood Plasma Derivatives Consumption by Type
        • 2.3.1 Global Bovine Blood Plasma Derivatives Consumption Market Share by Type (2014-2019)
        • 2.3.2 Global Bovine Blood Plasma Derivatives Revenue and Market Share by Type (2014-2019)
        • 2.3.3 Global Bovine Blood Plasma Derivatives Sale Price by Type (2014-2019)
      • 2.4 Bovine Blood Plasma Derivatives Segment by Application
        • 2.4.1 Scientific Research
        • 2.4.2 Industrial Production
        • 2.4.3 Feed
        • 2.4.4 Others
      • 2.5 Bovine Blood Plasma Derivatives Consumption by Application
        • 2.5.1 Global Bovine Blood Plasma Derivatives Consumption Market Share by Application (2014-2019)
        • 2.5.2 Global Bovine Blood Plasma Derivatives Value and Market Share by Application (2014-2019)
        • 2.5.3 Global Bovine Blood Plasma Derivatives Sale Price by Application (2014-2019)

      3 Global Bovine Blood Plasma Derivatives by Players

      • 3.1 Global Bovine Blood Plasma Derivatives Sales Market Share by Players
        • 3.1.1 Global Bovine Blood Plasma Derivatives Sales by Players (2017-2019)
        • 3.1.2 Global Bovine Blood Plasma Derivatives Sales Market Share by Players (2017-2019)
      • 3.2 Global Bovine Blood Plasma Derivatives Revenue Market Share by Players
        • 3.2.1 Global Bovine Blood Plasma Derivatives Revenue by Players (2017-2019)
        • 3.2.2 Global Bovine Blood Plasma Derivatives Revenue Market Share by Players (2017-2019)
      • 3.3 Global Bovine Blood Plasma Derivatives Sale Price by Players
      • 3.4 Global Bovine Blood Plasma Derivatives Manufacturing Base Distribution, Sales Area, Product Types by Players
        • 3.4.1 Global Bovine Blood Plasma Derivatives Manufacturing Base Distribution and Sales Area by Players
        • 3.4.2 Players Bovine Blood Plasma Derivatives Products Offered
      • 3.5 Market Concentration Rate Analysis
        • 3.5.1 Competition Landscape Analysis
        • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.6 New Products and Potential Entrants
      • 3.7 Mergers & Acquisitions, Expansion

      4 Bovine Blood Plasma Derivatives by Regions

      • 4.1 Bovine Blood Plasma Derivatives by Regions
        • 4.1.1 Global Bovine Blood Plasma Derivatives Consumption by Regions
        • 4.1.2 Global Bovine Blood Plasma Derivatives Value by Regions
      • 4.2 Americas Bovine Blood Plasma Derivatives Consumption Growth
      • 4.3 APAC Bovine Blood Plasma Derivatives Consumption Growth
      • 4.4 Europe Bovine Blood Plasma Derivatives Consumption Growth
      • 4.5 Middle East & Africa Bovine Blood Plasma Derivatives Consumption Growth

      5 Americas

      • 5.1 Americas Bovine Blood Plasma Derivatives Consumption by Countries
        • 5.1.1 Americas Bovine Blood Plasma Derivatives Consumption by Countries (2014-2019)
        • 5.1.2 Americas Bovine Blood Plasma Derivatives Value by Countries (2014-2019)
      • 5.2 Americas Bovine Blood Plasma Derivatives Consumption by Type
      • 5.3 Americas Bovine Blood Plasma Derivatives Consumption by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Bovine Blood Plasma Derivatives Consumption by Countries
        • 6.1.1 APAC Bovine Blood Plasma Derivatives Consumption by Countries (2014-2019)
        • 6.1.2 APAC Bovine Blood Plasma Derivatives Value by Countries (2014-2019)
      • 6.2 APAC Bovine Blood Plasma Derivatives Consumption by Type
      • 6.3 APAC Bovine Blood Plasma Derivatives Consumption by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Bovine Blood Plasma Derivatives by Countries
        • 7.1.1 Europe Bovine Blood Plasma Derivatives Consumption by Countries (2014-2019)
        • 7.1.2 Europe Bovine Blood Plasma Derivatives Value by Countries (2014-2019)
      • 7.2 Europe Bovine Blood Plasma Derivatives Consumption by Type
      • 7.3 Europe Bovine Blood Plasma Derivatives Consumption by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Bovine Blood Plasma Derivatives by Countries
        • 8.1.1 Middle East & Africa Bovine Blood Plasma Derivatives Consumption by Countries (2014-2019)
        • 8.1.2 Middle East & Africa Bovine Blood Plasma Derivatives Value by Countries (2014-2019)
      • 8.2 Middle East & Africa Bovine Blood Plasma Derivatives Consumption by Type
      • 8.3 Middle East & Africa Bovine Blood Plasma Derivatives Consumption by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Marketing, Distributors and Customer

      • 10.1 Sales Channel
        • 10.1.1 Direct Channels
        • 10.1.2 Indirect Channels
      • 10.2 Bovine Blood Plasma Derivatives Distributors
      • 10.3 Bovine Blood Plasma Derivatives Customer

      11 Global Bovine Blood Plasma Derivatives Market Forecast

      • 11.1 Global Bovine Blood Plasma Derivatives Consumption Forecast (2019-2024)
      • 11.2 Global Bovine Blood Plasma Derivatives Forecast by Regions
        • 11.2.1 Global Bovine Blood Plasma Derivatives Forecast by Regions (2019-2024)
        • 11.2.2 Global Bovine Blood Plasma Derivatives Value Forecast by Regions (2019-2024)
        • 11.2.3 Americas Consumption Forecast
        • 11.2.4 APAC Consumption Forecast
        • 11.2.5 Europe Consumption Forecast
        • 11.2.6 Middle East & Africa Consumption Forecast
      • 11.3 Americas Forecast by Countries
        • 11.3.1 United States Market Forecast
        • 11.3.2 Canada Market Forecast
        • 11.3.3 Mexico Market Forecast
        • 11.3.4 Brazil Market Forecast
      • 11.4 APAC Forecast by Countries
        • 11.4.1 China Market Forecast
        • 11.4.2 Japan Market Forecast
        • 11.4.3 Korea Market Forecast
        • 11.4.4 Southeast Asia Market Forecast
        • 11.4.5 India Market Forecast
        • 11.4.6 Australia Market Forecast
      • 11.5 Europe Forecast by Countries
        • 11.5.1 Germany Market Forecast
        • 11.5.2 France Market Forecast
        • 11.5.3 UK Market Forecast
        • 11.5.4 Italy Market Forecast
        • 11.5.5 Russia Market Forecast
        • 11.5.6 Spain Market Forecast
      • 11.6 Middle East & Africa Forecast by Countries
        • 11.6.1 Egypt Market Forecast
        • 11.6.2 South Africa Market Forecast
        • 11.6.3 Israel Market Forecast
        • 11.6.4 Turkey Market Forecast
        • 11.6.5 GCC Countries Market Forecast
      • 11.7 Global Bovine Blood Plasma Derivatives Forecast by Type
      • 11.8 Global Bovine Blood Plasma Derivatives Forecast by Application

      12 Key Players Analysis

      • 12.1 Thermo Fisher
        • 12.1.1 Company Details
        • 12.1.2 Bovine Blood Plasma Derivatives Product Offered
        • 12.1.3 Thermo Fisher Bovine Blood Plasma Derivatives Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.1.4 Main Business Overview
        • 12.1.5 Thermo Fisher News
      • 12.2 GE Healthcare
        • 12.2.1 Company Details
        • 12.2.2 Bovine Blood Plasma Derivatives Product Offered
        • 12.2.3 GE Healthcare Bovine Blood Plasma Derivatives Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.2.4 Main Business Overview
        • 12.2.5 GE Healthcare News
      • 12.3 Merck (Sigma-Aldrich)
        • 12.3.1 Company Details
        • 12.3.2 Bovine Blood Plasma Derivatives Product Offered
        • 12.3.3 Merck (Sigma-Aldrich) Bovine Blood Plasma Derivatives Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.3.4 Main Business Overview
        • 12.3.5 Merck (Sigma-Aldrich) News
      • 12.4 Moregate BioTech
        • 12.4.1 Company Details
        • 12.4.2 Bovine Blood Plasma Derivatives Product Offered
        • 12.4.3 Moregate BioTech Bovine Blood Plasma Derivatives Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.4.4 Main Business Overview
        • 12.4.5 Moregate BioTech News
      • 12.5 Gemini
        • 12.5.1 Company Details
        • 12.5.2 Bovine Blood Plasma Derivatives Product Offered
        • 12.5.3 Gemini Bovine Blood Plasma Derivatives Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.5.4 Main Business Overview
        • 12.5.5 Gemini News
      • 12.6 Atlanta Biologicals
        • 12.6.1 Company Details
        • 12.6.2 Bovine Blood Plasma Derivatives Product Offered
        • 12.6.3 Atlanta Biologicals Bovine Blood Plasma Derivatives Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.6.4 Main Business Overview
        • 12.6.5 Atlanta Biologicals News
      • 12.7 Tissue Culture Biologicals
        • 12.7.1 Company Details
        • 12.7.2 Bovine Blood Plasma Derivatives Product Offered
        • 12.7.3 Tissue Culture Biologicals Bovine Blood Plasma Derivatives Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.7.4 Main Business Overview
        • 12.7.5 Tissue Culture Biologicals News
      • 12.8 Bovogen
        • 12.8.1 Company Details
        • 12.8.2 Bovine Blood Plasma Derivatives Product Offered
        • 12.8.3 Bovogen Bovine Blood Plasma Derivatives Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.8.4 Main Business Overview
        • 12.8.5 Bovogen News
      • 12.9 Biowest
        • 12.9.1 Company Details
        • 12.9.2 Bovine Blood Plasma Derivatives Product Offered
        • 12.9.3 Biowest Bovine Blood Plasma Derivatives Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.9.4 Main Business Overview
        • 12.9.5 Biowest News
      • 12.10 Internegocios
        • 12.10.1 Company Details
        • 12.10.2 Bovine Blood Plasma Derivatives Product Offered
        • 12.10.3 Internegocios Bovine Blood Plasma Derivatives Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.10.4 Main Business Overview
        • 12.10.5 Internegocios News
      • 12.11 RMBIO
      • 12.12 Biological Industries
      • 12.13 VWR
      • 12.14 Corning
      • 12.15 Serana
      • 12.16 Lanzhou Minhai
      • 12.17 Zhejiang Tianhang Biotechnology
      • 12.18 ExCell Bio
      • 12.19 Jin Yuan Kang
      • 12.20 American Protein Company
      • 12.21 Sonac

      13 Research Findings and Conclusion

      Bovine Blood Plasma Derivatives covers different types of bovine blood plasma derivatives,and typically used in scientific research and industrial production.
      Thermo Fisher, GE Healthcare, Merck (Sigma-Aldrich), Moregate BioTech, Gemini, Atlanta Biologicals, Tissue Culture Biologicals and Bovogen are major players in this market. Relying on blood supply from around the world, Thermo Fisher, GE Healthcare and Merck (Sigma-Aldrich) are the world's three giants. In 2017, Merck (Sigma-Aldrich) is the world leader with a market share of 22.62%
      North America plays an important role in global bovine blood plasma derivatives market, especially United States, which has great influence on the development of bovine blood plasma derivatives. In Europe market, Germany, UK, France and Italy are playing significant roles, especially Germany, which has absolute predominance in Europe market. The Asia-Pacific will take an increasing significant part in global bovine blood plasma derivatives market, due to the strong demand from China, India and Southeast Asian countries.

      According to this study, over the next five years the Bovine Blood Plasma Derivatives market will register a 4.3% CAGR in terms of revenue, the global market size will reach US$ 2080 million by 2024, from US$ 1680 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Bovine Blood Plasma Derivatives business, shared in Chapter 3.

      This report presents a comprehensive overview, market shares, and growth opportunities of Bovine Blood Plasma Derivatives market by product type, application, key manufacturers and key regions and countries.

      This study considers the Bovine Blood Plasma Derivatives value and volume generated from the sales of the following segments:

      Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
      Bovine Serum
      FBS
      Bovine Serum Albumin
      Fibrinogen
      Protein Ingredient
      Other
      Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
      Scientific Research
      Industrial Production
      Feed
      Others

      This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
      Americas
      United States
      Canada
      Mexico
      Brazil
      APAC
      China
      Japan
      Korea
      Southeast Asia
      India
      Australia
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Middle East & Africa
      Egypt
      South Africa
      Israel
      Turkey
      GCC Countries

      The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
      Thermo Fisher
      GE Healthcare
      Merck (Sigma-Aldrich)
      Moregate BioTech
      Gemini
      Atlanta Biologicals
      Tissue Culture Biologicals
      Bovogen
      Biowest
      Internegocios
      RMBIO
      Biological Industries
      VWR
      Corning
      Serana
      Lanzhou Minhai
      Zhejiang Tianhang Biotechnology
      ExCell Bio
      Jin Yuan Kang
      American Protein Company
      Sonac

      In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

      Research objectives
      To study and analyze the global Bovine Blood Plasma Derivatives consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
      To understand the structure of Bovine Blood Plasma Derivatives market by identifying its various subsegments.
      Focuses on the key global Bovine Blood Plasma Derivatives manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
      To analyze the Bovine Blood Plasma Derivatives with respect to individual growth trends, future prospects, and their contribution to the total market.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      To project the consumption of Bovine Blood Plasma Derivatives submarkets, with respect to key regions (along with their respective key countries).
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
      To strategically profile the key players and comprehensively analyze their growth strategies.

      Buy now